✦ LIBER ✦

A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease

✍ Scribed by Martin B. Leon; Ran Kornowski; William E. Downey; Giora Weisz; Donald S. Baim; Robert O. Bonow; Robert C. Hendel; David J. Cohen; Ernest Gervino; Roger Laham; Nicholas J. Lembo; Jeffrey W. Moses; Richard E. Kuntz

Book ID: 119265331
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 156 KB
Volume: 46
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2005.06.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AT-1 receptor antagonism with candesarta

AT-1 receptor antagonism with candesartan cilexitil improves endothelial function in patients with hypertension and coronary artery disease: A double-blind, randomized, placebo-controlled trial

✍ Pasquale Perrone Filardi; Gregorio Brevetti; Antonio Silvestro; Luigi Corrado; M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Ustekinumab significantly improves sympt

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

✍ Richard G. Langley; Steven R. Feldman; Chenglong Han; Brad Schenkel; Philippe Sz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

✍ J Thambyrajah; M.J Landray; H.J Jones; F.J McGlynn; D.C Wheeler; J.N Townsend 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A randomized trial of aggressive lipid r

A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention

✍ Robert Fathi; Brian Haluska; Leanne Short; Thomas H Marwick 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Assessment of Pexelizumab in Acute Myoca

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

✍ Paul W. Armstrong; Peter X. Adams; Hussein R. Al-Khalidi; Christian Hamm; David 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Impact of High-Dose N-Acetylcysteine Ver

Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial

✍ Holger Thiele; Lysann Hildebrand; Carmen Schirdewahn; Ingo Eitel; Volker Adams; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB